Average deal value of biopharma M&A deals worldwide 2010-2019, by top companies
Between 2010 and 2019, the average value for merger and acquisition deals worldwide involving the biopharmaceutical company AbbVie was around 8.15 billion U.S. dollars. This statistic illustrates the average deal value made by select leading biopharma companies in the period 2010-2019.